Rapid Cavitary Pneumonia and Reversible Hepatic Injury in Burkholderia pseudomallei ST271 Infection

Nan Zhang1, Liang Li2, Fang Chen1

  • 1NHC Key Laboratory of Tropical Disease Control, School of Life Sciences and Medical Technology, Hainan Medical University, Haikou, Hainan, China.

Insights

A rare Burkholderia pseudomallei ST271 infection caused severe pneumonia and liver injury in an immunocompetent patient. Early sequencing and targeted therapy led to a full recovery, suggesting potential for phage therapy.

Area of Science:

  • Infectious Diseases
  • Genomics
  • Pulmonology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, presents with diverse clinical manifestations.
  • Sequence type (ST) 271 of B. pseudomallei is infrequently documented, with limited clinical and epidemiological data.
  • This case report details a rare instance of ST271 infection.

Purpose of the Study:

  • To describe a rare case of B. pseudomallei ST271 infection.
  • To highlight the clinical and epidemiological characteristics of this rare strain.
  • To emphasize the role of early diagnostics and treatment.

Main Methods:

  • Case report of a previously healthy 50-year-old male.
  • Chest CT imaging for pulmonary assessment.
  • Metagenomic and whole-genome sequencing of bronchoalveolar lavage fluid for pathogen identification and strain typing.
  • Antimicrobial susceptibility testing and preliminary bacteriophage susceptibility testing.

Main Results:

  • The patient presented with rapidly progressive cavitary pneumonia and acute hepatic injury.
  • B. pseudomallei ST271 was identified as the causative agent.
  • The strain exhibited sensitivity to imipenem, ceftazidime, and trimethoprim-sulfamethoxazole, with observed in vitro bacteriophage susceptibility.
  • The patient experienced rapid clinical improvement and resolution of symptoms following targeted antibiotic therapy.

Conclusions:

  • The rare B. pseudomallei ST271 strain can cause aggressive cavitary pneumonia and hepatic injury in immunocompetent individuals.
  • Early identification via sequencing is crucial for timely and effective treatment.
  • Successful treatment with ceftazidime and trimethoprim-sulfamethoxazole was achieved.
  • In vitro bacteriophage susceptibility suggests potential for novel therapeutic strategies against B. pseudomallei.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.2K
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
115
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K